Biotech News
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
investor.xenon-pharma.com2026-05-06 15:26 EST
VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today